The Medicines and Healthcare products Regulatory Agency (MHRA) recently published long-awaited guidance confirming that there will be a delay in the implementation of new legislation for the Great Britain market and an extension to the period during which CE-marked medical devices will be accepted in the Great Britain market. The guidance followed the transitional period extensions granted by the European Union earlier this year for legacy EU devices. The time periods set out in the MHRA…
By: McDermott Will & Emery
By: McDermott Will & Emery